BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tseng CH. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes. Front Oncol 2020;10:587666. [PMID: 33194743 DOI: 10.3389/fonc.2020.587666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tseng CH. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus. Biomolecules 2021;11:1226. [PMID: 34439890 DOI: 10.3390/biom11081226] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic Reprogramming in Cholangiocarcinoma. J Hepatol 2022:S0168-8278(22)00314-2. [PMID: 35594992 DOI: 10.1016/j.jhep.2022.04.038] [Reference Citation Analysis]
3 Tseng CH. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 2021;11:1022. [PMID: 34356646 DOI: 10.3390/biom11071022] [Reference Citation Analysis]